The Danish Society of Pharmacoepidemiology is honored to host a 2.5-hour online course on
transparency and reproducibility efforts in pharmacoepidemiology. The course will be taught by
Professor Anton Pottegård, University of Southern Denmark and Associate Professor Shirley V.
Wang, Harvard Medical School
Target population: All pharmacoepidemiologists who wish to improve the transparency and
reproducibility of their own science and contribute to advancing the field of pharmacoepidemiology
towards a more transparent future.
Nordic collaboration: We wish to strengthen collaboration between researchers in the Nordic
countries and therefore encourage participation from all Nordic countries.
Date: Wednesday, February 26th, 2025 from 1.30 PM CET
Place: Online participation (link will be sent to registered participants a few days before)
Registration: Register by selection the right “ticket” to the left. Sign up deadline is on February 24, 2024.
Price: Participation is free for students at Danish Universities, all PhD students, members of DSFE in Denmark and DURG Norge in Norway. For other participants, the course fee is DKK 500. We encourage everyone to become a member of DSFE.
Recommended reading: Am J Epi (DOI: 10.1093/aje/kwae087)
Course responsible: DSFE
Speaker bios
Shirley Wang is an Associate Professor at Brigham and Women’s Hospital, Harvard Medical School where she leads the Meta-Research in Pharmacoepidemiology program. Several recent projects were aimed at improving the transparency, reproducibility and robustness of evidence from healthcare databases (www.repeatinitiative.org) and informing when and how real-world evidence studies can draw causal conclusions to inform regulatory or other healthcare decision-making (www.rct-duplicate.org), through a series of large scale emulation projects offering insights into what types of clinical questions can be answered with real-world data and which methods are the most robust.
Anton Pottegård is a pharmacoepidemiologist and clinical pharmacist working as a professor at the University of Southern Denmark, leading a team of more than 40 researchers. His research focuses on the use of drugs in its broadest sense and with more than 350 publications within pharmacoepidemiology he is highly established both within applied and methodological research.